natgillin/translations-raw huggingface dataset:
If you have missed a dose of Insuman Comb 30 or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Comb 30 ali ste če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Insuman Comb 30 or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Comb 30 ali če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Insuman Comb 30 or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Comb 30 če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Insuman Comb 50 or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Comb 50 ali če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Insuman Comb 50 or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Comb 50 če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Insuman Infusat or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Infusat ali če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Insuman Rapid or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Rapid ali če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Insuman Rapid or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Insuman Rapid če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zveča (hiperglikemija).
If you have missed a dose of Lantus or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Lantus ali če si niste injicirali dovolj insulina, se vam lahko koncentracija krvnega sladkorja preveč zviša (hiperglikemija).
If you have missed a dose of Toujeo or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
Če ste izpustili odmerek zdravila Toujeo ali če si niste injicirali dovolj insulina, se vam lahko koncentracija krvnega sladkorja preveč zviša (hiperglikemija).
If you have missed a dose, contact your doctor for advice.
Če ste pozabili vzeti odmerek, se posvetujte z zdravnikom.
If you have missed a dose, take it as soon as you remember.
Če pozabite vzeti odmerek, ga vzemite takoj ko se spomnite.
If you have missed an Aldurazyme infusion, please contact your doctor.
Če niste dobili infuzije zdravila Aldurazyme, se posvetujte s svojim zdravnikom.
If you have missed an Elaprase infusion, please contact your doctor.
Če ste izpustili infuzijo zdravila Elaprase, se obrnite na svojega zdravnika.
If you have missed an infusion of Fabrazyme, please contact your doctor.
Če niste prejeli odmerka zdravila Fabrazyme, se obrnite na svojega zdravnika.
If you have missed an infusion, please contact your doctor.
Če ste izpustili infuzijo, obvestite svojega zdravnika.
If you have missed an injection, contact your doctor as soon as possible.
Če ste izpustili injekcijo, se čim prej posvetujte z zdravnikom.
If you have missed less than 7 days of treatment with Fycompa, continue taking your daily dose as originally instructed by your doctor.
Če ste izpustili manj kot 7 dni zdravljenja z zdravilom Fycompa, nadaljujte z jemanjem odmerka vsak dan, kot vam je prvotno naročil vaš zdravnik.
If you have missed less than 7 days of treatment with Fycompa, continue taking your daily tablet as originally instructed by your doctor.
Če ste izpustili manj kot 7 dni zdravljenja z zdravilom Fycompa, nadaljujte z jemanjem tablete vsak dan, kot vam je prvotno naročil vaš zdravnik.
If you have missed more than 7 days of treatment with Fycompa, talk to your doctor immediately.
Če ste izpustili več kot 7 dni zdravljenja z zdravilom Fycompa, se takoj posvetujte z zdravnikom.
If you have missed one or more periods
Če niste dobili ene ali več menstruacij
If you have missed one or more periods If you stop taking IOA
Če niste dobili ene ali več menstruacij Če prenehate z jemanjem zdravila IOA
If you have missed several doses, please inform your doctor and follow the advice given to you
Če ste izpustili več odmerkov, prosimo obvestite svojega zdravnika in upoštevajte njegova navodila.
If you have missed two or more doses talk to your doctor.
Če ste pozabili vzeti dva ali več odmerkov, se posvetujte z zdravnikom.
If you have moderate or severe heart failure.
Če imate zmerno ali hudo srčno popuščanje.
if you have moderate or severe kidney disease
če imate zmerno ali hudo bolezen ledvic.
If you have moderate or severe kidney disease, your doctor will prescribe a lower dose.
Vaš zdravnik vam bo morda moral prilagoditi odmerek ali zdravilo ukiniti.
if you have moderate or severe kidney disease. if you are currently taking any other iron chelator medicines.
če imate zmerno ali hudo bolezen ledvic, če trenutno jemljete katero koli drugo zdravilo, ki kelira železo.
If you have moderate or severe kidney problems
če imate zmerne ali hude težave z ledvicami,
if you have moderate or severe kidney problems if you have liver problems.
če imate zmerne do hude težave z ledvicam, če imate težave z jetri.
If you have moderate or severe kidney problems this medicine should not be used.
Če pa imate zmerno ali hudo ledvično bolezen, tega zdravila ne smete uporabljati.
if you have moderate or severe kidney problems. if you have a condition that reduces your body’s ability to fight infections, such as a disease like AIDS or from medicines that you might take after an organ transplant.
če imate zmerne ali hude težave z ledvicami. če imate kakšno stanje, ki zmanjšuje sposobnost telesa za premagovanje okužb, npr. bolezen, kakršna je AIDS, ali če prejemate zdravila, ki se uporabljajo po presaditvi organa.
if you have moderate or severe liver disease if you have ever had liver disease, including hepatitis B or C
če imate zmerno ali hudo bolezen jeter, če ste kdaj imeli bolezen jeter, vključno s hepatitisom B ali C,
if you have moderate or severe liver disease if you have ever had liver disease, including hepatitis B or C (if you have hepatitis B infection, do not stop Kivexa without your doctor’s advice, as your hepatitis may come back)
če imate zmerno ali hudo bolezen jeter; če ste kdaj imeli bolezen jeter, vključno s hepatitisom B ali C (če imate okužbo s hepatitisom B, ne prenehajte jemati zdravila Kivexa brez nasveta vašega zdravnika, saj se lahko hepatitis ponovi);
If you have moderate or severe liver disease, your doctor will limit your dose to the lower strength of Relvar Ellipta (92/22 micrograms once daily).
Če imate zmerno ali hudo bolezen jeter, vam bo zdravnik odmerek omejil na manjšo jakost zdravila Relvar Ellipta (92/22 mikrogramov enkrat na dan);
if you have moderate or severe liver problem. if you experience rapid weight loss, feeling sick or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat, contact a doctor or the nearest hospital straight away.
če imate zmerne ali hude težave z jetri. če se vam pojavijo hitra izguba telesne mase, slabost ali bruhanje, bolečine v trebuhu, prekomerna žeja, hitro in globoko dihanje, zmedenost, neobičajna zaspanost ali utrujenost, sladek vonj izdihanega zraka, sladek ali kovinski okus v ustih ali spremenjen vonj urina ali znoja, se takoj posvetujte z zdravnikom ali pojdite v najbližjo bolnišnico.
if you have moderate or severe liver problems. if you are using certain medicines to treat bacterial infections (clarithromycin, telithromycin), fungal infections (itraconazole, ketoconazole, voriconazol, posaconazol), HIV infection (protease inhibitors), depression (nefazodone) or heart rhythm disorders (e.g. quinidine, dofetilide, or sotalol).
če imate zmerne ali hude težave z jetri; če uporabljate nekatera zdravila za zdravljenje bakterijskih okužb (klaritromicin ali telitromicin), glivičnih okužb (itrakonazol, ketokonazol, vorikonazol ali posakonazol), okužbe z virusom HIV (zaviralce proteaze), depresije (nefazodon) ali motenj srčnega ritma (npr. kinidin, dofetilid ali sotalol).
If you have moderate or severe problems with liver function, your doctor may need to reduce the dose of Orkambi as your liver will not clear Orkambi as fast as in people who have normal liver functions.
Če imate zmerne ali resne težave z delovanjem jeter, vam bo moral zdravnik mogoče zmanjšati odmerek zdravila Orkambi, ker vaša jetra ne odstranijo zdravila Orkambi iz krvi tako hitro kot pri ljudeh, pri katerih jetra normalno delujejo.
if you have moderate or severe renal disease; lower doses (< 1 mg/kg) may be needed
če imate zmerno ali hudo bolezen ledvic; morda bodo potrebni nižji odmerki (< 1 mg/kg)
If you have moderate to severe kidney function problems, your doctor will monitor you.
Če imate zmerne do hude težave z delovanjem ledvic, vas bo zdravnik nadzoroval.
If you have moderate to severe kidney function problems, your doctor will monitor you.
Če imate zmerne do hude težave z ledvičnim delovanjem, vas bo zdravnik nadzoroval.
if you have moderate to severe kidney or liver impairment if you are using other medicines which affect the production of blood cells in the bone marrow (myelosuppression).
če imate zmerno do hudo okvarjeno delovanje ledvic ali jeter če jemljete druga zdravila, ki vplivajo na nastajanje krvnih celic v kostnem mozgu (mielosupresija)
if you have moderate to severe kidney problems,
če imate zmerne do hude težave z ledvicami,
if you have moderate to severe liver or kidney disease
če imate zmerno hudo do hudo jetrno ali ledvično bolezen;
if you have moderate to severe liver problems
če imate zmerno do hudo okvaro jeter.
if you have moderate to severe liver problems.
če imate zmerno do hudo okvaro jeter.
If you have more Briviact than you should
Če ste prejeli večji odmerek zdravila Briviact, kot bi smeli
If you have more CellCept than you should
Če ste prejeli večji odmerek zdravila CellCept, kot bi smeli
If you have multiple sclerosis, your doctor will decide if you should receive Trudexa
Če imate multiplo sklerozo, bo zdravnik presodil, ali lahko dobivate Trudexo.
If you have multiple sclerosis, your doctor will decide if you should receive Trudexa.
Če imate multiplo sklerozo, bo zdravnik presodil, ali lahko dobivate Trudexo.
if you have myasthenia gravis (a disease affecting the muscles),
če imate miastenijo gravis (bolezen, ki prizadene mišice);
if you have myasthenia gravis (a disease marked by abnormal tiredness and weakness of selected muscles).
če imate miastenijo gravis (bolezen, za katero sta značilni nenormalna utrujenost in šibkost nekaterih mišic),
If you have myasthenia gravis (chronic neuromuscular weakness).
Če imate miastenijo gravis (kronično živčnomišično slabost).
if you have myasthenia gravis (very weak or tired muscles). if you have severe breathing or chest problems.
če imate miastenijo gravis (zelo šibke ali utrujene mišice). če imate hude težave z dihanjem ali prsnim košem.
If you have myelodysplastic syndromes, you may be more likely to get a more advanced condition called acute myeloid leukaemia (AML).
Če imate mielodisplastične sindrome, boste verjetneje dobili bolj napredovalo bolezen, ki se imenuje akutna mieloična levkemija (AML).
if you have narrow-angle glaucoma (an eye disorder);
če imate glavkom z ozkim zakotjem (očesno bolezen);
if you have narrowing of the aortic valve (aortic stenosis) or cardiogenic shock (a condition where your heart is unable to supply enough blood to the body).
če imate zoženje aortne zaklopke (aortno stenozo) ali kardiogeni šok (stanje, v katerem srce ne more črpati dovolj močno, da bi oskrbelo telo s krvjo);
if you have never had chickenpox.
če nikoli niste preboleli noric;
If you have never had chickenpox: If you have never had chickenpox, your doctor will check your immunity against the virus that causes it (varicella zoster virus).
Če nikoli niste preboleli noric: če nikoli niste preboleli noric, bo zdravnik pregledal vašo imunost proti virusu, ki povzroča norice (proti virusu varicella zoster).
If you have never had herpes infection in the past, you may be more likely to get fever, chills, and flu- like illnesses within the period of the first 6 treatments with Imlygic.
Če nikdar v preteklosti niste imeli okužbe s herpesom, je verjetneje, da se vam bodo v obdobju prvih 6 zdravljenj z zdravilom Imlygic pojavile zvišana telesna temperatura, mrzlica in gripi podobna bolezen.
If you have never had levodopa before, the usual starting dose for Numient is one 95 mg capsule three times a day for three days.
Če nikoli prej niste jemali levodope, je običajni začetni odmerek zdravila Numient ena 95- miligramska kapsula trikrat na dan, tri dni.
If you have not applied a patch for more than three days, do not apply the next one before you have talked to your doctor.
Če obliža niste namestili več kot dni, ne nameščajte novega obliža, dokler se ne pogovorite s svojim zdravnikom.
If you have not applied a patch for more than three days, do not apply the next one before you have talked to your doctor.
Če obliža niste namestili več kot tri dni, ne nameščajte novega obliža, dokler se ne pogovorite s svojim zdravnikom.
If you have not applied a patch for several days, do not apply the next one before you have talked to your doctor.
Če obliža niste namestili več dni, ne nameščajte naslednjega, dokler se ne pogovorite s svojim zdravnikom.
If you have not been exposed to it, you are at a higher risk of getting a type of cancer called post- transplant lymphoproliferative disorder (PTLD).
Pri bolnikih, ki virusu niso bili izpostavljeni, obstaja večje tveganje za razvoj maligne bolezni, imenovane potransplantacijska limfoproliferativna bolezen (PTLB).
If you have not been previously treated with chemotherapy, your first dose of Temodal will be 200 mg/m2 once daily for the first 5 days.
Če se v preteklosti niste zdravili s kemoterapijo, bo prvi odmerek zdravila Temodal 200 mg/m2 enkrat na dan prvih 5 dni.
If you have not been previously treated with chemotherapy, your first dose of Temomedac will be 200 mg/m² once daily for the first 5 days.
Če se v preteklosti niste zdravili s kemoterapijo, bo prvi odmerek zdravila Temomedac 200 mg/m2 enkrat na dan prvih 5 dni.
If you have not been treated before for mantle cell lymphoma you will receive Bortezomib Accord intravenously or subcutaneously together with the medicines rituximab, cyclophosphamide, doxorubicin and prednisone.
Če vam limfoma plaščnih celic še niso zdravili,boste zdravilo Bortezomib Accord prejeli v veno, skupaj z rituksimabom, ciklofosamidom, doksorubicinom in prednizonom.
If you have not been treated before for mantle cell lymphoma you will receive Bortezomib SUN intravenously or subcutaneously together with the medicines rituximab, cyclophosphamide, doxorubicin and prednisone.
Če vam limfoma plaščnih celic še niso zdravili, boste zdravilo Bortezomib SUN prejeli v veno, skupaj z rituksimabom, ciklofosamidom, doksorubicinom in prednizonom.
If you have not been treated before for multiple myeloma, and you are not suitable for blood stem cell transplantation you will receive bortezomib intravenously or subcutaneously together with two other medicines; melphalan and prednisone.
Če vam diseminiranega plazmocitoma še niso zdravili in presaditev krvotvornih matičnih celic za vas ni primerna, vam bodo bortezomib injicirali v veno ali v podkožje skupaj z zdraviloma melfalan in prednizon.
If you have not been treated before for multiple myeloma, and you are suitable for blood stem cell transplantation you will receive Bortezomib SUN intravenously or subcutaneously together with the medicines dexamethasone, or dexamethasone and thalidomide, as induction treatment:
Če pri vas diseminiranega plazmocitoma še niso zdravili in je presaditev krvotvornih matičnih celic za vas primerna, boste kot uvajalno zdravljenje prejeli zdravilo Bortezomib SUN v veno ali v podkožje v kombinaciji z deksametazonom ali z deksametazonom in talidomidom:
If you have not been vaccinated against meningococcal infection (unlessyou take antibiotics to reduce the risk of infection until 2 weeks after you have been vaccinated ).
če niste bili cepljeni proti meningokokni okužbi (razen če jemljete antibiotike za zmanjšanje tveganja okužbe, dokler ne mineta 2 tedna po cepljenju); če imate meningitis.
If you have not experienced a positive effect of Intrinsa within 3-6 months, you should inform your doctor, who will suggest that treatment be discontinued.
Če ugodnega učinka zdravila Intrinsa ne opazite v 3–6 mesecih, morate obvestiti svojega zdravnika, ki vam bo predlagal, da zdravljenje prekinete.
If you have not experienced a positive effect of Livensa within 3-6 months, you should inform your doctor, who will suggest that treatment be discontinued.
Če ugodnega učinka zdravila Livensa ne opazite v 3–6 mesecih, morate obvestiti svojega zdravnika, ki vam bo predlagal, da zdravljenje prekinete.
If you have not previously received doses of Prepandrix or Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg
Če predhodno niste prejeli odmerkov cepiva Prepandrix ali cepiva Prepandemično cepivo proti gripi (H5N1) (z delci virionov, inaktivirano, z adjuvansom) GlaxoSmithKline Biologicals 3,75 µg.
If you have not received this training please ask your doctor, nurse or pharmacist to show you how to use your inhaler properly before you use it for the first time.
Če vas ni nihče naučil uporabljati inhalatorja, pred prvo uporabo prosite zdravnika, medicinsko sestro ali farmacevta, da vam pokaže, kako morate pravilno uporabljati inhalator.
If you have not responded sufficiently to treatment after 7 days, your doctor may consider giving you a repeat dose of 150 mg or 2 mg/kg.
Če 7 dni po začetku zdravljenja ne pride do zadostnega odziva na zdravljenje, vam bo zdravnik morda dal ponoven odmerek 150 mg oziroma 2 mg/kg.
If you have not responded to treatment after 4 months, your doctor may suggest that you continue using these two medicines for at least 18 months.
Če se po 4 mesecih ne odzovete na zdravljenje, vam bo zdravnik morda predlagal, da nadaljujete z uporabo teh dveh zdravil vsaj 18 mesecev.
If you have not responded to treatment after 4 months, your doctor may suggest that you continue using these two medicines for at least 18 months.
Če se po štirih mesecih ne odzovete na zdravljenje, vam bo zdravnik morda predlagal, da nadaljujete uporabo teh dveh zdravil vsaj 18 mesecev.
If you have not taken all the tablets correctly, or if your expected period does not happen twice in a row, you may be pregnant.
Če vseh tablet niste vzeli pravilno ali če dvakrat zapored niste imeli pričakovane menstruacije, ste lahko noseči.
If you have not taken Rivastigmine HEXAL for more than three days, do not take the next dose until you have talked to your doctor.
Če zdravila Rivastigmin HEXAL niste vzeli več kot tri dniveč kot tri dni, ne vzemite naslednjega odmerka, dokler se ne posvetujete z zdravnikom.
If you have not used Instanyl for 7 days or more, the nasal spray must be primed again by spraying once before the next dose is taken.
Če izdelka niste uporabljali več kot 7 dni, morate pršilo za nos pred novim odmerkom ponovno pripraviti z enkratnim proženjem.
If you have not used Instanyl for more than 7 days the pump must be primed again by spraying once before the next dose is taken.
Če zdravila Instanyl niste uporabljali več kot 7 dni, morate pred uporabo naslednjega odmerka z enkratnim pritiskom na pršilo sprostiti nekaj zdravila v zrak.
if you have now or have had in past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/ or long-standing cough) if you have heart problems such as low heart rate, heart block, or heart failure
če imate ali ste v preteklosti imeli bolezen dihal, kot je astma, hud kronični obstruktivni bronhitis (huda pljučna bolezen, ki lahko povzroči sopihanje, težave z dihanjem in/ali dolgotrajni kašelj); če imate težave s srcem, kot npr. upočasnjen srčni utrip, srčni blok ali srčno popuščanje.
if you have now or have had in the past respiratory problems such as asthma, sever chronic obstructive bronchitis (severe lung condition which may cause wheezing, difficulty in breathing and/or long standing cough) or other types of breathing problems.
če imate ali ste imeli v preteklosti težave z dihali, na primer astmo, hud kronični obstrukcijski bronhitis (hudo stanje pljuč, ki lahko povzroči zasoplost, težko dihanje in/ali dolgotrajni kašelj) ali druge težave z dihanjem.
if you have or are suspected to have cancer. if you have had cancer in the gastrointestinal tract, including liver, gallbladder or bile ducts, within the last five years.
če imate raka ali če obstaja sum, da imate raka. če ste imeli v zadnjih petih letih raka prebavil, vključno z jetri, žolčnikom ali žolčevodi.
If you have or could have an infection of your womb (uterus).
Če imate ali bi lahko imeli okužbo maternice (uterusa).
If you have or develop demyelinating disease such as multiple sclerosis, your doctor will decide if you should receive or continue to receive Humira.
Če imate ali pa se pri vas razvija demielinizirajoča bolezen, kot je multipla skleroza, bo zdravnik presodil, ali lahko dobivate oziroma tudi še nadalje dobivate zdravilo Humira.
If you have or develop demyelinating disease such as multiple sclerosis, your doctor will decide if you should receive or continue to receive Humira.
Če imate ali pa se pri vas razvija demielinizirajoča bolezen, kot je multipla skleroza, bo zdravnik presodil, ali lahko dobivate zdravilo Humira.
If you have or develop demyelinating disease such as multiple sclerosis, your doctor will decide if you should receive or continue to receive Humira.
Če imate ali se pri vas razvija demielinizirajočo bolezen, kot je multipla skleroza, bo zdravnik presodil, ali lahko dobivate oziroma tudi še nadalje dobivate zdravilo Humira.
If you have or develop multiple sclerosis or another demyelinating disease, your doctor will decide if you should receive or continue to receive Humira.
Če imate ali pa se pri vas razvija demielinizirajoča bolezen, kot je multipla skleroza, bo zdravnik presodil, ali lahko dobivate zdravilo Humira.
If you have or develop severe kidney or liver problems, this treatment will be stopped.
Če imate hude težave z delovanjem ledvic ali jeter oz. če se tovrstne težave pojavijo, bo zdravljenje ustavljeno.
If you have or develop severe kidney or liver problems, this treatment will be stopped.
Če imate hude težave z ledvicami ali jetri oz. če se tovrstne težave pojavijo, bo zdravljenje ustavljeno.
If you have or develop severe kidney or liver problems, this treatment will be stopped.
Če imate hude težave z ledvicami ali jetri oziroma če se tovrstne težave pojavijo, bo zdravljenje ustavljeno.
if you have or ever had bladder cancer. if you have blood in your urine that your doctor has not checked.
če imate ali ste imeli rak mehurja; če imate kri v urinu, ki ga zdravnik ni preiskal.
if you have or ever had bleeding problems,
če imate ali ste kdaj imeli težave s krvavitvijo,
if you have or ever had liver problems,
če imate ali ste kdaj imeli težave z jetri,